A Post-authorization Safety Study to Evaluate the Safety of Multiple Myeloma Patients Treated with Ciltacabtagene Autoleucel

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  Center for International Blood & Marrow Transplant Research (CIMBTR) Cellular Therapy Registry United States, Janssen-sponsored PASS 68284528MMY4009 Belgium
• Data sources (types):
  Disease registry

  Other
• Data sources (types), other:
  Spontaneous reporting system, Prospective patient-based data collection

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No